Search results

ANSTO physicist will gain further experience in particle therapy technologies.

An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

The project aims to engage the wider cultural heritage community in addition to our internal research.

Tool developed for producing F-18 radiopharmaceuticals for PET imaging.

Following a decade of imaging to support research and clinical trials at ANSTO and the University of Sydney’s Brain and Mind Centre at Camperdown, two PET scanners have been transferred to the University of Wollongong.

Using PET and simulations to verify the accuracy of dose and range in advanced therapy with heavy ions

Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.

The Australian Academy of Technology and Engineering (ATSE) has elected Professor Andrew Peele, Director of ANSTO’s Australian Synchrotron, to become a Fellow of the prestigious organisation.

New high energy ion microprobe beamline supports space research on the effects of radiation on astronauts.

Dr Anne Hellstedt has been appointed Director of ANSTO’s Innovation Precinct.

Research on lunar meteorite and moon crater analogues coincides with Science Week.

Useful in some mineral processes but a major problem in others, jarosite may be the key to unlocking the geological history and environmental context of water on Mars.